Mark Leibowitz
Publications by Year
Research Areas
SARS-CoV-2 and COVID-19 Research, COVID-19 Clinical Research Studies, Receptor Mechanisms and Signaling, Cholinesterase and Neurodegenerative Diseases, Neuroscience and Neuropharmacology Research
Most-Cited Works
- → Pharmacokinetics and Pharmacodynamics of the Novel Daily Rivastigmine Transdermal Patch Compared With Twice-daily Capsules in Alzheimer's Disease Patients(2007)128 cited
- → Safety and efficacy of pioglitazone for the delay of cognitive impairment in people at risk of Alzheimer's disease (TOMMORROW): a prognostic biomarker study and a phase 3, randomised, double-blind, placebo-controlled trial(2021)111 cited
- → Efficacy and safety of sibutramine for weight loss in obese patients with hypertension well controlled by β-adrenergic blocking agents: a placebo-controlled, double-blind, randomised trial(2002)79 cited
- → Gender and pramipexole effects on levodopa pharmacokinetics and pharmacodynamics(2002)72 cited
- → Single‐Dose Administration of MK‐0657, an NR2B‐Selective NMDA Antagonist, Does Not Result in Clinically Meaningful Improvement in Motor Function in Patients With Moderate Parkinson's Disease(2009)62 cited
- → QT Effects of Duloxetine at Supratherapeutic Doses: A Placebo and Positive Controlled Study(2007)58 cited
- → Low Penetration of Oseltamivir and Its Carboxylate into Cerebrospinal Fluid in Healthy Japanese and Caucasian Volunteers(2008)57 cited
- → Effects of encapsulation on absorption of sumatriptan tablets: data from healthy volunteers and patients during a migraine(2001)41 cited
- → A Randomized, Double-Blind, Placebo-Controlled, Multicenter, 28-Day, Polysomnographic Study of Gabapentin in Transient Insomnia Induced by Sleep Phase Advance(2014)38 cited
- → The Effects of Supratherapeutic Doses of Duloxetine on Blood Pressure and Pulse Rate(2007)35 cited